xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 72593 | MHCI alpha (51-61) | FragmentOfANaturalSequenceMolecule | Peptide from protein | WIEQEGPEYWD | 11 | null | 50 | 60 | 9606 | CAB43622.1 | null | Exact Epitope | Representative selection | MhcBinding | 2467907 | 286 | Figure 1 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 13818 | MHCI alpha (53-63) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EQEGPEYWDQE | 11 | null | 52 | 62 | 9606 | CAB43622.1 | null | Exact Epitope | Representative selection | MhcBinding | 2467911 | 286 | Figure 1 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 72592 | MHCI alpha (51-60) | FragmentOfANaturalSequenceMolecule | Peptide from protein | WIEQEGPEYW | 10 | null | 50 | 59 | 9606 | CAB43622.1 | null | Exact Epitope | Representative selection | MhcBinding | 2468079 | 286 | Figure 3 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 72592 | MHCI alpha (51-60) | FragmentOfANaturalSequenceMolecule | Peptide from protein | WIEQEGPEYW | 10 | null | 50 | 59 | 9606 | CAB43622.1 | null | Exact Epitope | Representative selection | MhcBinding | 2467913 | 286 | Figures 1, 2, and 3 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 25938 | MHCI alpha (52-60) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IEQEGPEYW | 9 | null | 51 | 59 | 9606 | CAB43622.1 | null | Exact Epitope | Representative selection | MhcBinding | 2467915 | 286 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 25937 | MHCI alpha (52-59) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IEQEGPEY | 8 | null | 51 | 58 | 9606 | CAB43622.1 | null | Exact Epitope | Representative selection | MhcBinding | 2467917 | 286 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 32925 | CLIP (85-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLMQALP | 18 | null | 102 | 119 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468081 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 32925 | CLIP (85-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLMQALP | 18 | null | 102 | 119 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468082 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 32924 | CLIP (85-101) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLMQAL | 17 | null | 102 | 118 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468104 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 32924 | CLIP (85-101) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLMQAL | 17 | null | 102 | 118 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468105 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 108199 | CLIP (87-101) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VSKMRMATPLLMQAL | 15 | null | 104 | 118 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468107 | 286 | Figure 5 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 108199 | CLIP (87-101) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VSKMRMATPLLMQAL | 15 | null | 104 | 118 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468108 | 286 | Figure 5 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 131549 | Ii chain P1 (80-92) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LPKPPKPVSKMRM | 13 | null | 97 | 109 | 9606 | AAH24272.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 2468498 | 91 | Table 1 | Positive | true | null | null | null | null | null | 103 | null | null | null | null | null | null | null | 5 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422944 | CLIP (86-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PVSKMRMATPLLMQALP | 17 | null | 103 | 119 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468505 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422944 | CLIP (86-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PVSKMRMATPLLMQALP | 17 | null | 103 | 119 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468506 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 71016 | CLIP (87-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VSKMRMATPLLMQALP | 16 | null | 104 | 119 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468507 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 71016 | CLIP (87-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VSKMRMATPLLMQALP | 16 | null | 104 | 119 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468508 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422948 | CLIP (88-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SKMRMATPLLMQALP | 15 | null | 105 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468509 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422948 | CLIP (88-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SKMRMATPLLMQALP | 15 | null | 105 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468510 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 234135 | CLIP (89-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KMRMATPLLMQALP | 14 | null | 106 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468511 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 234135 | CLIP (89-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KMRMATPLLMQALP | 14 | null | 106 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468512 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422943 | CLIP CLIP (90-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | MRMATPLLMQALP | 13 | null | 107 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468513 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422943 | CLIP CLIP (90-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | MRMATPLLMQALP | 13 | null | 107 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468514 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 54855 | CLIP (91-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RMATPLLMQALP | 12 | null | 108 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468515 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 54855 | CLIP (91-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RMATPLLMQALP | 12 | null | 108 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468516 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422936 | CLIP (92-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | MATPLLMQALP | 11 | null | 109 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468517 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422936 | CLIP (92-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | MATPLLMQALP | 11 | null | 109 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468518 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422920 | CLIP (93-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATPLLMQALP | 10 | null | 110 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468519 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422920 | CLIP (93-102) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATPLLMQALP | 10 | null | 110 | 119 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468520 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422933 | CLIP (85-100) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLMQA | 16 | null | 102 | 117 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468523 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422933 | CLIP (85-100) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLMQA | 16 | null | 102 | 117 | 9606 | P04233.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2468524 | 286 | Figure 4 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422931 | CLIP (85-98) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLM | 14 | null | 102 | 115 | 9606 | NP_001020330.1 | null | Exact Epitope | Representative selection | MhcBinding | 2468527 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422931 | CLIP (85-98) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLLM | 14 | null | 102 | 115 | 9606 | NP_001020330.1 | null | Exact Epitope | Representative selection | MhcBinding | 2468528 | 286 | Figure 4 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422930 | CLIP (85-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLL | 13 | null | 102 | 114 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468529 | 286 | Figure 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422930 | CLIP (85-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPLL | 13 | null | 102 | 114 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468530 | 286 | Figure 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422929 | CLIP (85-96) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPL | 12 | null | 102 | 113 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468531 | 286 | Figure 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422929 | CLIP (85-96) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATPL | 12 | null | 102 | 113 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468532 | 286 | Figure 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422928 | CLIP (85-95) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATP | 11 | null | 102 | 112 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468533 | 286 | Figure 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422928 | CLIP (85-95) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMATP | 11 | null | 102 | 112 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468534 | 286 | Figure 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422927 | CLIP (85-94) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMAT | 10 | null | 102 | 111 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468535 | 286 | Figure 4 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315228.xml | 315228 | 2025-11-06-08:00 | 9321428 | 1,997 | Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. | Immunogenetics | Y van de Wal; Y M Kooy; J W Drijfhout; R Amons; G K Papadopoulos; F Koning | 422927 | CLIP (85-94) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KPVSKMRMAT | 10 | null | 102 | 111 | 9606 | P04233.3 | null | Exact Epitope | Representative selection | MhcBinding | 2468536 | 286 | Figure 4 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22068 | Chlamydial hsp60 (35-48) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRHVVIDKSFGSPQ | 14 | null | 35 | 48 | 813 | P17203 | null | Exact Epitope | Not determined | TCell | 1382737 | 69 | Figures 4 and 5 | Positive | true | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22068 | Chlamydial hsp60 (35-48) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRHVVIDKSFGSPQ | 14 | null | 35 | 48 | 813 | P17203 | null | Exact Epitope | Not determined | TCell | 1382739 | 69 | Figure 4 | Negative | false | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22068 | Chlamydial hsp60 (35-48) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRHVVIDKSFGSPQ | 14 | null | 35 | 48 | 813 | P17203 | null | Exact Epitope | Not determined | TCell | 1382736 | 69 | Figures 1 and 2 | Positive | true | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Not determined | Not determined | null | 4 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22068 | Chlamydial hsp60 (35-48) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRHVVIDKSFGSPQ | 14 | null | 35 | 48 | 813 | P17203 | null | Exact Epitope | Not determined | TCell | 316314 | 69 | Figure 3 | Positive | true | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22068 | Chlamydial hsp60 (35-48) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRHVVIDKSFGSPQ | 14 | null | 35 | 48 | 813 | P17203 | null | Exact Epitope | Not determined | TCell | 1382740 | 69 | Figure 4 | Negative | false | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Not determined | Not determined | null | 4 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22068 | Chlamydial hsp60 (35-48) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRHVVIDKSFGSPQ | 14 | null | 35 | 48 | 813 | P17203 | null | Exact Epitope | Not determined | TCell | 1382738 | 69 | Figure 4 | Negative | false | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Not determined | Not determined | null | 4 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22068 | Chlamydial hsp60 (35-48) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRHVVIDKSFGSPQ | 14 | null | 35 | 48 | 813 | P17203 | null | Exact Epitope | Not determined | TCell | 1382735 | 69 | Figures 1, 2, and 3 | Positive | true | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Not determined | Not determined | null | 4 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22157 | E. coli hsp60 (35-50) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRNVVLDKSFGAPQIT | 16 | null | null | null | 562 | null | null | Epitope containing region/antigenic site | Internal Identifier-no external match available | TCell | 1382741 | 69 | Figures 4 and 5 | Positive | true | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Exact match to reference information | Not determined | null | 9 |
315229.xml | 315229 | 2025-11-06-08:00 | 9328119 | 1,997 | Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. | Clinical and experimental immunology | K H Deane; R M Jecock; J H Pearce; J S Gaston | 22219 | human hsp60 (35-50) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRTVIIEQGWGSPKVT | 16 | null | 59 | 74 | 9606 | AAA36022.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1382744 | 69 | Figure 4 | Negative | false | null | 9606 | M | 28 years | DOID:104 | 63 | null | T cell CD4+ | synovial fluid | Cell Line / Clone | Exact match to reference information | Not determined | null | 1 |
315233.xml | 315233 | 2025-11-06-08:00 | 9382929 | 1,997 | HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes. | Immunogenetics | V Tieng; N Dulphy; F Boisgérault; R Tamouza; D Charron; A Toubert | 55602 | L7A (234-242) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRHWGGNVL | 9 | null | 234 | 242 | 9606 | P62424.2 | null | Exact Epitope | Representative selection | MhcLigandElution | 1711114 | 93 | Table 2 | Positive | true | null | null | null | null | null | 192 | null | null | null | null | null | null | null | 9 |
315233.xml | 315233 | 2025-11-06-08:00 | 9382929 | 1,997 | HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes. | Immunogenetics | V Tieng; N Dulphy; F Boisgérault; R Tamouza; D Charron; A Toubert | 122782 | ATPase (293-301) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRFDVKIEV | 9 | null | 293 | 301 | 9606 | P05026.1 | null | Exact Epitope | Representative selection | MhcLigandElution | 1711115 | 93 | Table 2 | Positive | true | null | null | null | null | null | 192 | null | null | null | null | null | null | null | 9 |
315233.xml | 315233 | 2025-11-06-08:00 | 9382929 | 1,997 | HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes. | Immunogenetics | V Tieng; N Dulphy; F Boisgérault; R Tamouza; D Charron; A Toubert | 122818 | KRFKGQIGL | FragmentOfANaturalSequenceMolecule | Peptide from protein | KRFKGQIGL | 9 | null | null | null | 32644 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcLigandElution | 1711116 | 93 | Table 2 | Positive | true | null | null | null | null | null | 192 | null | null | null | null | null | null | null | 8 |
315233.xml | 315233 | 2025-11-06-08:00 | 9382929 | 1,997 | HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes. | Immunogenetics | V Tieng; N Dulphy; F Boisgérault; R Tamouza; D Charron; A Toubert | 122890 | RRVGXQVNL | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRVGXQVNL | 9 | null | null | null | 32644 | null | null | Exact Epitope | Internal Identifier-no external match available | MhcLigandElution | 1711118 | 93 | Table 2 | Positive | true | null | null | null | null | null | 192 | null | null | null | null | null | null | null | 3 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 59278 | NY-ESO-1 (157-165) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLLMWITQC | 9 | null | 157 | 165 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940175 | 67 | Table 1 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 2 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 59278 | NY-ESO-1 (157-165) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLLMWITQC | 9 | null | 157 | 165 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940176 | 63 | Figure 4 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 2 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 59278 | NY-ESO-1 (157-165) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLLMWITQC | 9 | null | 157 | 165 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940179 | 63 | Figures 3 and 4 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Representative selection | Representative selection | null | 2 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 59278 | NY-ESO-1 (157-165) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLLMWITQC | 9 | null | 157 | 165 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940181 | 67 | Figure 2 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Representative selection | Representative selection | null | 2 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 167652 | NY-ESO-1 (155-163) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLSLLMWIT | 9 | null | 155 | 163 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940182 | 67 | Figure 2 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Representative selection | Representative selection | null | 5 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 167652 | NY-ESO-1 (155-163) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLSLLMWIT | 9 | null | 155 | 163 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940177 | 67 | Table 1 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 5 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 167652 | NY-ESO-1 (155-163) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLSLLMWIT | 9 | null | 155 | 163 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940178 | 63 | Figure 4 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 5 |
315236.xml | 315236 | 2025-11-06-08:00 | 9432985 | 1,998 | Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. | The Journal of experimental medicine | E Jäger; Y T Chen; J W Drijfhout; J Karbach; M Ringhoffer; D Jäger; M Arand; H Wada; Y Noguchi; E Stockert; L J Old; A Knuth | 167652 | NY-ESO-1 (155-163) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QLSLLMWIT | 9 | null | 155 | 163 | 9606 | P78358.1 | null | Exact Epitope | Representative selection | TCell | 1940180 | 63 | Figures 3 and 4 | Positive | true | null | 9606 | F | 81 years | DOID:8923 | 143 | null | T cell | blood | Cell Line / Clone | Representative selection | Representative selection | null | 5 |
315241.xml | 315241 | 2025-11-06-08:00 | 9461441 | 1,998 | The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. | Science (New York, N.Y.) | J M den Haan; L M Meadows; W Wang; J Pool; E Blokland; T L Bishop; C Reinhardus; J Shabanowitz; R Offringa; D F Hunt; V H Engelhard; E Goulmy | 138924 | HA-1<sup>R</sup> | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLRDDLLEA | 9 | null | 166 | 174 | 9606 | BAA13212.1 | null | Exact Epitope | Author provided Identifier | MhcBinding | 1809531 | 273 | Figure 4 | Positive-Low | true | 365.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315241.xml | 315241 | 2025-11-06-08:00 | 9461441 | 1,998 | The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. | Science (New York, N.Y.) | J M den Haan; L M Meadows; W Wang; J Pool; E Blokland; T L Bishop; C Reinhardus; J Shabanowitz; R Offringa; D F Hunt; V H Engelhard; E Goulmy | 138937 | YIGEVLVSV | FragmentOfANaturalSequenceMolecule | Peptide from protein | YIGEVLVSV | 9 | null | 41 | 49 | 9606 | NP_149043.2 | null | Exact Epitope | Representative selection | MhcBinding | 1810724 | 273 | Figure 4 | Positive | true | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132071 | P1 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SPATWTTRGFVFTRHSQTTA | 20 | null | 1,437 | 1,456 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444260 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132071 | P1 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SPATWTTRGFVFTRHSQTTA | 20 | null | 1,437 | 1,456 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444270 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132110 | P2 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VFTRHSQTTAIPSCPEGTVPL | 21 | null | 1,447 | 1,467 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444259 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132110 | P2 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VFTRHSQTTAIPSCPEGTVPL | 21 | null | 1,447 | 1,467 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444261 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 143142 | P3a | FragmentOfANaturalSequenceMolecule | Peptide from protein | TTAIPSCPEGTVPLYSGFSF | 20 | null | 1,454 | 1,473 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444291 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 143142 | P3a | FragmentOfANaturalSequenceMolecule | Peptide from protein | TTAIPSCPEGTVPLYSGFSF | 20 | null | 1,454 | 1,473 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444313 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 142704 | P3b | FragmentOfANaturalSequenceMolecule | Peptide from protein | GTVPLYSGFSFLFVQGNQRAHG | 22 | null | 1,463 | 1,484 | 9606 | Q01955.3 | null | Exact Epitope | Representative selection | MhcLigandElution | 2444703 | 92 | Tables V, VII and VIII | Positive | true | null | null | null | null | null | 326 | 336 | null | null | null | null | null | null | 2 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 142704 | P3b | FragmentOfANaturalSequenceMolecule | Peptide from protein | GTVPLYSGFSFLFVQGNQRAHG | 22 | null | 1,463 | 1,484 | 9606 | Q01955.3 | null | Exact Epitope | Representative selection | MhcBinding | 2444298 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 142704 | P3b | FragmentOfANaturalSequenceMolecule | Peptide from protein | GTVPLYSGFSFLFVQGNQRAHG | 22 | null | 1,463 | 1,484 | 9606 | Q01955.3 | null | Exact Epitope | Representative selection | MhcBinding | 2444278 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131973 | P4 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LYSGFSFLFVQGNQRAHGQD | 20 | null | 1,467 | 1,486 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444299 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131973 | P4 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LYSGFSFLFVQGNQRAHGQD | 20 | null | 1,467 | 1,486 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444279 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132569 | P5 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QGNQRAHGQDLGTLGSCLQR | 20 | null | 1,477 | 1,496 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444292 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132569 | P5 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QGNQRAHGQDLGTLGSCLQR | 20 | null | 1,477 | 1,496 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444314 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131946 | P6 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LGTLGSCLQRFTTMPFLFCN | 20 | null | 1,487 | 1,506 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444293 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131946 | P6 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LGTLGSCLQRFTTMPFLFCN | 20 | null | 1,487 | 1,506 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444300 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131881 | P7 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FTTMPFLFCNVNDVCNFASR | 20 | null | 1,497 | 1,516 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444301 | 273 | Figure 1 and Table III | Positive | true | 1700.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131881 | P7 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FTTMPFLFCNVNDVCNFASR | 20 | null | 1,497 | 1,516 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444280 | 273 | Figure 1 and Table III | Positive | true | 2000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132113 | P8 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VNDVCNFASRNDYSYWLSTPA | 21 | null | 1,507 | 1,527 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444302 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132113 | P8 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VNDVCNFASRNDYSYWLSTPA | 21 | null | 1,507 | 1,527 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444281 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132494 | P9 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NDYSYWLSTPALMPMNMAPI | 20 | null | 1,517 | 1,536 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444303 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132494 | P9 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NDYSYWLSTPALMPMNMAPI | 20 | null | 1,517 | 1,536 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444282 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131822 | P10 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALMPMNMAPITGRALEPYIS | 20 | null | 1,527 | 1,546 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444304 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131822 | P10 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALMPMNMAPITGRALEPYIS | 20 | null | 1,527 | 1,546 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444283 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132094 | P11 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TGRALEPYISRCTVCEGPAI | 20 | null | 1,537 | 1,556 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444310 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132094 | P11 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TGRALEPYISRCTVCEGPAI | 20 | null | 1,537 | 1,556 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444287 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132040 | P12 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RCTVCEGPAIAIAVHSQTTD | 20 | null | 1,547 | 1,566 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444294 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132040 | P12 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RCTVCEGPAIAIAVHSQTTD | 20 | null | 1,547 | 1,566 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444305 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131816 | P13 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AIAVHSQTTDIPPCPHGWIS | 20 | null | 1,557 | 1,576 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444273 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131816 | P13 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AIAVHSQTTDIPPCPHGWIS | 20 | null | 1,557 | 1,576 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444263 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131919 | P14 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IPPCPHGWISLWKGFSFIMF | 20 | null | 1,567 | 1,586 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444295 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131919 | P14 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IPPCPHGWISLWKGFSFIMF | 20 | null | 1,567 | 1,586 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444288 | 273 | Figure 1 | Positive | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131972 | P15 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LWKGFSFIMFTSAGSEGTGQ | 20 | null | 1,577 | 1,596 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444284 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131972 | P15 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LWKGFSFIMFTSAGSEGTGQ | 20 | null | 1,577 | 1,596 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444289 | 273 | Figure 1 | Positive-High | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132104 | P16 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TSAGSEGTGQALASPGSCLE | 20 | null | 1,587 | 1,606 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444265 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 132104 | P16 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TSAGSEGTGQALASPGSCLE | 20 | null | 1,587 | 1,606 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444274 | 273 | Figure 1 | Negative | false | 100000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315250.xml | 315250 | 2025-11-06-08:00 | 9565555 | 1,998 | Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. | The Journal of biological chemistry | R G Phelps; V L Jones; M Coughlan; A N Turner; A J Rees | 131820 | P17 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALASPGSCLEEFRASPFLEC | 20 | null | 1,597 | 1,616 | 9606 | Q01955.3 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 2444306 | 273 | Figure 1 and Table III | Positive | true | 12000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.